A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome - Contacts and Locations

Home

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

This study has been completed.

Study NCT00001839. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001839

Locations


United States, Maryland
	Warren G. Magnuson Clinical Center (CC)
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Institutes of Health Clinical Center (CC)